Drug candidates spanning oncology, neurology, rare diseases and more are approaching critical development as the calendar turns to 2026.

KDIGO's new IgA nephropathy guideline shifts the treatment paradigm from supportive care alone to targeting the disease's immunologic nature.

IgA nephropathy can shorten life expectancy by 10 years on average. Life expectancy can depend on several factors, including kidney function at diagnosis, protein levels in the urine, age, other ...

Investigators studied IgA nephropathy relapse, its correlation with kidney failure, and risk factors using a prospective cohort.

RemeGen has submitted a Biologics License Application (BLA) to the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) in China for IgAN, which if approved would ...

ST. GALLEN, Switzerland, and SAN DIEGO, Sept. 26, 2025 /PRNewswire/ -- CSL Vifor and Travere Therapeutics, Inc., (NASDAQ: TVTX) support the recent publication of the updated clinical practice ...

GFR is key marker of kidney function; IgAN is progressive autoimmune kidney disease that leads to kidney failure in many patients 1-3 Fabhalta is first and only approved complement inhibitor for ...

Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced that the Company will present 11 abstracts, including a late-breaking poster, at the upcoming American Society of Nephrology (ASN) Kidney Week ...

Sept 24 (Reuters) - Acadia Pharmaceuticals (ACAD.O), opens new tab said on Wednesday it will discontinue development of its intranasal therapy to treat a rare genetic condition after it failed to show ...

Sen Ted Cruz (R-TX) almost certainly did not mean it when he said Democrats and Republicans should come together to “stop attacking pedophiles” — with the congressman making the unfortunate remark ...

President Trump, Texas Sen. Ted Cruz and other Republicans impassionately called on lefty pols to stop “demonizing” Immigration and Customs Enforcement officers after a deadly shooting at a Dallas ...